Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Keyphrases

• Disease Burden 100%
• Disease Management 100%
• Management Approach 100%
• Health Care Surveys 100%
• Systemic Mastocytosis 100%
• Healthcare Professionals 64%
• Oncologists 23%
• Immunologist 23%
• Allergist 23%
• Hematologist 23%
• Symptom Onset 17%
• KIT mutation 17%
• Illness Perceptions 17%
• Unmet Needs 11%
• Advanced Systemic Mastocytosis 11%
• Immunology 5%
• Provider Characteristics 5%
• Clinical Practice 5%
• Allergy 5%
• Patient Well-being 5%
• Neoplasms 5%
• Lay Summary 5%
• Improved Survival 5%
• Low Dose Rate 5%
• Patient Management 5%
• Management Strategy 5%
• Current Management 5%
• Disease Impact 5%
• Prevalence Estimation 5%
• Symptom Improvement 5%
• US Health Care 5%
• Treatment Goals 5%
• Rare Diseases 5%
• Years of Practice 5%
• Oncohematology 5%
• Long Delay 5%
• Practice Experience 5%
• Indolent Systemic Mastocytosis 5%
• Perception Strategies 5%
• Clinical Perceptions 5%
• Educational Management 5%
• Management Priorities 5%

Medicine and Dentistry

• Disease Management 100%
• Disease Burden 100%
• Systemic Mastocytosis 100%
• Health Care Provider 63%
• Oncologist 21%
• Disease 15%
• Neoplasm 5%
• Immunology 5%
• Prevalence 5%
• Patient Care 5%
• Quality of Life 5%
• Oncology 5%
• Hematology 5%
• Rare Disease 5%
• Indolent Systemic Mastocytosis 5%